Majority of U.S. level III & IV NICUs in 2025 used Prolacta’s 100% breastmilk-based fortifiers & formulas to improve outcomes for premature infants
Type: Press Releases
Topic(s): Company
Meet thriving Prolacta micro-preemies Rosie & Tommy along with their generous donor mom, Emily
Type: Parent Stories Prolacta in the News
Topic(s): 22 weeker 22-27 weeks (extremely premature) 24 weeker Parents
Most comprehensive meta-analysis to date finds an exclusive human milk diet is associated with up to 49% lower risk of necrotizing enterocolitis in premature infants
Type: Press Releases
Topic(s): Company Product
Babies Jesse & Ezekiel's story of resilience, advocacy, and hope
Type: Parent Stories Prolacta in the News
Topic(s): 22-27 weeks (extremely premature) Parents
Donor Melanie is committed to her patients and NICU babies
Type: Donor Stories
Topic(s): Tiny Treasures
Prolacta Bioscience approaches 20 years nourishing extremely premature babies as #1 hospital provider of human milk-based fortifiers and formulas
Type: Press Releases
Topic(s): Company Product
NICU Awareness Month milestone: 125,000 preemies helped by Prolacta Bioscience’s 100% breast milk-based nutrition
Type: Press Releases
Topic(s): Company
Mom of Prolacta Baby Lincoln “the Legend” gives back
Type: Parent Stories
Topic(s): 22 weeker 22-27 weeks (extremely premature) Parents
Study: Despite being born earlier and weighing less, preemies fed Prolacta’s Exclusive Human Milk Diet had lower motor skill disability risk by age 3 compared to larger preemies fed cow milk-based products
Type: Press Releases
Topic(s): Clinical Studies Long-Term outcomes
Not finding the reference you’re looking for?
Use our main search field or email us at info@prolacta.com